Copyright & Legal Disclaimers
On this page:
COPYRIGHTS & TRADEMARKS
All content and images used on this site are owned or licensed by Baxter International Inc. or its affiliates ("Baxter") for use on this site only. Unauthorized use is prohibited.
Names of Baxter products and services are trademarks of Baxter International Inc., or its subsidiaries.
Nothing contained herein shall be construed as conferring any license or right under any Baxter patent, copyright or trademark.
THIS SITE CONTAINS INFORMATION CONCERNING BAXTER AND ITS AFFILIATES THAT MAY BE USEFUL TO BAXTER’S CUSTOMERS, SUPPLIERS, EMPLOYEES AND SHAREHOLDERS, AS WELL AS MEMBERS OF THE GENERAL PUBLIC. HOWEVER, BY USING THIS SITE YOU ARE ACCEPTING ALL OF THE TERMS OF THIS DISCLAIMER NOTICE, INCLUDING EXCLUSIONS AND LIMITATIONS OF LIABILITY. IF YOU DO NOT AGREE WITH ANYTHING IN THIS NOTICE YOU SHOULD NOT USE THIS WEBSITE.
WHILE REASONABLE EFFORTS ARE MADE TO ENSURE THAT THE CONTENTS OF THIS SITE ARE ACCURATE, THIS SITE AND ITS CONTENTS ARE PROVIDED ON AN “AS IS,” “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, INCLUDING ANY WARRANTY THAT THE SITE WILL BE KEPT UP TO DATE, BE TRUE AND NOT MISLEADING OR THAT THE SITE WILL ALWAYS (OR EVER) BE AVAILABLE FOR USE. BAXTER AND ITS AFFILIATES DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO THE SITE AND ITS CONTENTS, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF ACCURACY, COMPLETENESS, TIMELINESS, NON-INFRINGEMENT, TITLE, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. BECAUSE SOME JURISDICTIONS DO NOT PERMIT THE EXCLUSION OF CERTAIN WARRANTIES, THESE EXCLUSIONS MAY NOT APPLY TO YOU.
BAXTER DOES NOT WARRANT THAT THE SERVERS THAT MAKE THIS SITE AVAILABLE WILL BE ERROR, VIRUS, WORM OR BUG FREE AND YOU ACCEPT THAT IT IS YOUR RESPONSIBILITY TO MAKE ADEQUATE PROVISION FOR PROTECTION AGAINST SUCH THREATS.
BAXTER HAS NOT REVIEWED ALL THE SITES THAT MAY BE LINKED TO ITS SITES AND DOES NOT ENDORSE AND IS NOT RESPONSIBLE FOR THE CONTENT OF ANY OFF-SITE PAGES OR ANY OTHER SITES LINKED TO THESE SITES. YOUR LINKING TO SUCH SITES IS AT YOUR OWN RISK.
IN NO EVENT WILL BAXTER OR ITS AFFILIATES BE LIABLE FOR ANY INCIDENTAL, INDIRECT, CONSEQUENTIAL OR SPECIAL DAMAGES OF ANY KIND, OR ANY DAMAGES WHATSOEVER, INCLUDING, WITHOUT LIMITATION, THOSE RESULTING FROM LOSS OF PROFITS, CONTRACTS, GOODWILL, DATA, INFORMATION, INCOME, ANTICIPATED SAVINGS OR BUSINESS RELATIONSHIPS, WHETHER OR NOT BAXTER OR ITS AFFILIATES HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE, ARISING OUT OF OR IN CONNECTION WITH THE USE OF THIS SITE OR ITS CONTENTS OR ANY OTHER SITES LINKED TO THIS SITE.
Baxter websites contain information about products which may or may not be available in any particular country, and if applicable, may have received approval or market clearance by a governmental regulatory body for different indications and restrictions in different countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information about medical products on the Internet. Nothing herein should be construed as a solicitation or promotion for any product or for an indication for any product which is not authorized by the laws and regulations of the country where the reader resides.
This site may contain information on medical and health-related topics. This information is not meant to be a substitute for the advice provided by your own physician or other medical professional. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.
The matters discussed on this website that are not historical facts include forward-looking statements concerning the company's financial results, business development activities, R&D pipeline and outlook for 2013, including as impacted by the Gambro AB acquisition. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance of risks for new and existing products, such as ADVATE, and other technologies; future actions of regulatory bodies and other governmental authorities that could delay, limit or suspend product development, manufacturing or sales or result in sanctions; product quality or patient safety concerns leading to product recalls, withdrawals, launch delays, litigation, or declining sales; future actions of governmental authorities and other third parties as U.S. healthcare reform legislation and other austerity measures are implemented globally; additional legislation, regulation and other governmental pressures, which may affect pricing, taxation, reimbursement and rebate policies of government agencies and private payers or other elements of the company's business; product development risks, including satisfactory clinical performance; the company's ability to realize the anticipated benefits from its business development and R&D activities, including the ability to successfully integrate the Gambro acquisition; inventory reductions or fluctuations in buying patterns by wholesalers or distributors; the impact of geographic and product mix on the company's sales; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies; the availability of acceptable raw materials and component supply; fluctuations in supply and demand and the pricing of plasma-based therapies; the ability to enforce company patents; patents of third parties preventing or restricting the company's manufacture, sale or use of affected products or technology; the impact of global economic conditions on Baxter and its customers, including foreign governments in certain countries in which the company operates; foreign currency fluctuations and other risks identified in the company's most recent filing on Form 10-K and other Securities and Exchange Commission filings, all of which are available on the company's website. The company does not undertake to update its forward-looking statements. Financial schedules are attached to this release and available on the company's website.